InsidersTradesSigma
Discover the detailed record of transactions filed by Patel Priti, Directeur Médical. Director active across 1 company, notably Neoleukin Therapeutics, Inc.. In total, 1 reports have been logged. History available since 30 April 2022. The latest transaction was disclosed on 30 April 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Priti Patel is the Chief Medical Officer of Neoleukin Therapeutics, Inc. She is responsible for medical leadership and innovation in treatment development. Her expertise is essential to ensure the safety and efficacy of the company's products.